We describe the clinical presentation and outcome in a series of eight patients with systemic necrotizing vasculitis and severe alpha t -antitrypsin (AAT) deficiency followed up at three Swedish hospitals during 1968-92. We also review six other cases reported in the literature during the same period. Diagnosis of severe AAT deficiency was based on the presence of the PiZZ phenotype, or low plasma total trypsin inhibitory capacity, or a low plasma AAT concentration (10-40% of the normal mean value) and presence of the PiSZ or PiFZ phenotype. The diagnosis of systemic vasculitis was biopsy-verified in all eight patients. Pretreatment laboratory findings, treatment protocol, and outcome were reviewed in each of the 14 patients. Of the eight patients in the Swedish series, six had systemic vasculitis of the microscopic polyangiitis form, one had Wegener's granulomatosis, and another had Henoch-Schonlein purpura. In the series as a whole ( n = 1 4 ) , median age at diagnosis was 48 years (range 44-84), the median number of affected organs was eight, and all 14 patients had skin involvement, and either renal or joint involvement (in most cases both); 7 1 % (10/14) had emphysema; 57% (8/14) had hepatic abnormalities (two having cirrhosis, two fibrosis, and one multiple aneurysms in hepatic arteries); one patient who presented with acute ulcerative colitis developed manifest vasculitic syndrome three years later; and 64% (9/14) died, the major cause of death being renal failure. This syndrome, characterized by multiple organ involvement and fatal outcome, has been underdiagnosed. Physicians should be alert to the presence of the PiZ AAT deficiency gene in patients with systemic vasculitis, especially when the course is progressive or when the patient also has emphysema or cirrhosis. Awareness of those features may aid prompt recognition and enable early treatment.
Introduction
Severe alphaT-antitrypsin (AAT) deficiency is an autosomal recessive disorder characterized by reduced plasma levels of AAT and clinically associated with progressive development of emphysema, liver disease or both. 1 The deficiency state is due to mutations of the AAT gene, a pleomorphic 12.2 kb 7-exon gene located as a pair of codominant autosomal alleles on chromosome 14 at q31-31.3.
2
Serum AAT concentration is controlled by a set of 75 different alleles of the AAT gene, any two of which define the phenotype of the individual. The phenotype is designated by letters denoting their electrophoretic mobility, in terms of the protease inhibitor (Pi) type. PiMM is the most common phenotype, present in approximately 90% of the Swedish population. The PiZZ phenotype, which occurs in 0.06% of the Swedish population, is associated with profoundly low serum levels of AAT (15-20% of normal) and with lung and liver disease. Rarely observed phenotypes that are associated with
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low serum AAT levels include PiSZ, PiFZ, and Pi-null (people with non-expressing alleles). The systemic necrotizing vasculitides comprise a heterogenous group of conditions characterized by widespread focal and segmental inflammation with acute infiltrates of polymorphonuclear leucocytes and later monocytes, and fibrinoid necrosis in blood vessel walls and perivascular interstitial spaces. Arteries, capillaries, and sometimes veins, of various sizes and in different locations throughout the body may be involved, resulting in a great diversity of symptoms and signs. The pathogenic mechanisms that produce inflammatory lesions in the various forms of vasculitis have yet to be elucidated, but it is likely that there are many. The recent description of autoantibodies to neutrophil cytoplasmic antigens (ANCA), 3 ' 4 and to endothelial cells 5 " 7 which are frequent in these diseases, suggests that autoimmunity may be one of these mechanisms. Under indirect immunofluorescence, proteinase 3 (PR3) antibodies manifest a classic ANCA (c-ANCA) pattern. PR3 is inhibited by AAT and the levels of complexes between these proteins have been found to be low in patients with the PiZ allele for AAT deficiency and Wegener's granulomatosis. 8 Although a number of case reports, 9 
Methods
Of eight Swedish patients diagnosed as having systemic vasculitis and severe AAT deficiency during the period 1968-92, four were identified at University Hospital, Malmo (with a catchment area population of 240000), two at the Lowenstromska Hospital, Stockholm County (catchment area population 90000), and two at University Hospital, Lund (catchment area population 100 000). Three cases were traced in the Swedish national registry of individuals with severe AAT deficiency of the PiZZ phenotype, the other five cases were cases seen by us, two of them having been mentioned previously. 22 Patients were included only if there was unequivocal evidence of multisystemic vasculitis based on histological findings of inflammatory conditions as necrotizing vasculitis, leucocytoclastic vasculitis, crescentic glomerulonephritis or segmental necrotizing glomerulonephritis, together with symptoms and signs of general inflammation, and simultaneous or successive involvement of at least two organs or systems which could not be explained by any other disease such as infection, atherosclerosis or malignancy. Six patients had a systemic vasculitis compatible with microscopic polyangiitis, one patient had Wegener's granulomatosis, and one had Henoch-Schonlein purpura (HSP). The American College of Rheumatology (ACR) 1990 criteria for diagnosis were used to classify patients with Wegener's granulomatosis 23 and HSP. 24 As microscopic polyangiitis was not included in the ACR 1990 classification criteria, microscopic polyangiitis and classical polyarteritis nodosa were defined according to the Chapel Hill consensus conference definitions. 25 The diagnosis of severe AAT deficiency was based on the presence of the PiZZ phenotype, or correspondingly low plasma total trypsin inhibitory capacity or plasma AAT concentrations (i.e. 10-40% of the normal mean value) and presence of the PiSZ phenotype. One patient had the PiFZ phenotype and repeatedly low plasma AAT levels (0.3-0.4 g/l). The literature concerning systemic vasculitis and severe AAT deficiency was located with the help of the Index Medicus or the Medline system, six cases reported in detail being traced and, together with the eight Swedish patients, yielding a series of 14 patients. We gathered further information about two of the cases located in the literature, patients 11 1 1 and 13, 13 by writing to the corresponding author of each report. More information was also obtained about patient 14, whom we reported briefly in a previous study. 16 Pretreatment laboratory findings were recorded. If several tests results were available the highest or the lowest, as appropriate, was recorded. Normal ranges vary slightly from one laboratory to another, and methods may have been changed over the years. The current normal ranges at University Hospital, Malmo, are as follows: haemoglobin 11.5-16.6 g/dl, white blood cell count (WBC) 4-10.0 x 10 9 /l, platelet count 125-340 x 10 9 /l, erythrocyte sedimentation rate (ESR) 2-32 mm/h, serum creatinine 60-115 umol/l, and plasma AAT 0.97-1.68 g/l. The latter was measured as previously described, 26 and
Pi phenotypes for AAT deficiency were determined by isoelectric focusing as previously described. 27 The treatment protocol, main cause of treatment, and outcome were also reviewed in each case.
Results
The Swedish series consisted of eight patients, four men and four women, all with severe AAT deficiency, median age at diagnosis 48 years (range Table 1 presents the demographic data, diagnosis, and organ involvement putatively related to severe AAT deficiency in these eight patients as well as in the six from the literature.
Clinical presentation
The presenting signs and symptoms in the two groups are summarized in Table 2 . Most patients initially presented with skin, lung, renal and/or joint disease. Skin rash and arthropathy were the most frequent clinical findings (in 100% and 79% respectively). The degrees of organ involvement in all 14 patients are listed in order of frequency in Figure 1 . The median number of affected organs was eight in the series as a whole (n = 14). All patients had skin involvement, and either renal or joint involvement (usually both). Only three patients (22%) lacked evidence of lung involvement of any sort.
Skin
All 14 patients manifested clinical evidence of some form of cutaneous abnormality, such as erythematous and/or necrotizing papules, vesicles, palpable purpura, subcutaneous nodules, erythematous plaques, and spontaneous severe relapsing ulcerative paniculitis. In the Swedish series, skin biopsy was performed in 75% (6/8) of cases, the histopathological findings being necrotizing vasculitis in five cases and nonspecific inflammation in one case. In all six literature cases, histological findings were available: 67% (4/6) of them had leucocytoclastic vasculitis, i.e. a necrotizing vasculitis but with less fibrinoid necrosis and more leucocytoclasia than in necrotizing vasculitis, and 33% (2/6) had necrotizing vasculitis. The skin disease generally responded promptly to specific treatment, and was a minor problem for the patients except in two cases. In patient 4, widespread severe ulcerative panniculitis was, together with polyradiculitis, the principal indication for initiating immunosuppressive therapy; the skin biopsy manifested necrotizing vasculitis of subcutaneous vessels, and analysis of an exudate from a panniculitis ulcer showed the presence of an elastase-like proteinase (human leucocyte elastase, HLE) and non-specific collagenase (PR3), both of which were in part free and in part complexed with AAT. In patient 3, the leg ulcers were very slow to heal.
Kidneys
Of the Swedish series, 88% (7/8) had documented renal disease, confirmed by percutaneous renal biopsy and/or autopsy in five patients and after nephrectomy in one patient, whereas the remaining patient had pathological urinary sediment. Nephritic syndrome, i.e. presence of microscopic haematuria and granular casts in addition to a high plasma creatinine concentration, was present in 63% (5/8) of the patients (3, 5, 6, 7 and 8) . Isolated chronic microscopic haematuria was seen in patient 2. Nephrotic syndrome, with proteinuria of 7 g/day, was found in patient 1, who had PiFZ phenotype. This might have contributed to her low plasma AAT level (30-40% of normal, instead of about 60% as seen in a healthy PiFZ individual). Kidney biopsy showed the presence of focal segmental necrotizing and crescentic glomerulonephritis ( Figure 2 ), and at autopsy both kidneys were found to be atrophied with hyalino-sclerosis of the majority of glomeruli. Patient 2 had, in addition to chronic haematuria, a unilateral hydronephrosis due to ureteral compression by periureteral retroperitoneal fibrosis, in turn due to necrotizing small-vessel vasculitis. Renal failure was severe in three patients (1, 6 and 8), necessitating dialysis and, in patient 1, renal transplantation. The histological findings included focal segmental necrotizing and crescentic glomerulonephritis in five patients (1, 3, 5, 6 and 8) , all with rapidly progressive glomerulonephritis, and necrotizing vasculitis of intraparenchymal renal small-sized arteries, and arterioles in one case. At autopsy, the histological findings in the rejected kidney (patient 1) were vascular lesions with the same characteristics as in accelerated acute rejection ( Figure 3 ). All six patients in the literature series had documented renal disease, confirmed by percutaneous renal biopsy and/or autopsy in five cases. Isolated microscopic haematuria was found in patient 11, nephrotic syndrome in patient 9, and nephritic syndrome in four patients (10, 12, 13 and 14) . The glomerulonephritis was rapidly progressive in at least three (9, 10 and 12) . One patient had severe renal failure at presentation, necessitating dialysis. The histological findings included focal segmental necrotizing and crescentic glomerulonephritis in four (9, 10, 12 and 14) , and focal segmental mesangio- 
N, normal; NS, not stated; E, emphysema; CB, chronic bronchitis, i.e. daily productive cough for three consecutive months for two consecutive years; F, fibrosis; C, cirrhosis; NV, necrotizing vasculitis; PLE, panlobular emphysema. * According to the American College of Rheumatology and the classification of vasculitides adopted by the Chapel Hill consensus conference; proliferative and necrotizing glomerulonephritis in patient 13. In the latter case, immunofluorescence showed the presence of mesangial deposits of IgA, IgG and fibrin on the subendothelial aspect of the glomerular basement membrane.
Respiratory tract
Pulmonary abnormalities were present in 88% (7/8) of the Swedish series, compared to 67% (4/6) of the literature series, and in many patients were the dominant feature (Table 1) . In all, emphysema was found in 7 1 % (10/14) of cases. Panlobular emphysema was evident histologically in four patients, one of whom was a non-smoker. Emphysema was diagnosed on clinical grounds in the remaining six patients, i.e. based on lung function tests and low gas transfer, four of whom were non-smokers. Necrotizing vasculitis of bronchial and/or pulmonary arteries was found in three patients (6, 8 and 9) (Figure 4 ). Bilateral pleural effusions were seen in two cases (4 and 9), being in part haemorrhagic in patient 4, who had severe generalized oedema and severe hypoalbuminaemia, suggesting a capillary leak syndrome. Haemoptysis was the chief complaint in two patients (5 and 9), being recurrent in patient 5. The only patient with Wegener's granulomatosis in this series (patient 3) had clinical signs of upper respiratory tract involvement in the form of otitis and sinusitis, the latter also being evident at X-ray of his paranasal sinuses, although multiple nasal biopsies had only shown the presence of non-specific inflammation.
Joints
Arthropathy was a common and early manifestation. Of the Swedish series, 75% (6/8) had some form of joint involvement during the course of the disease, whereas 83% (5/6) of the literature series had arthropathy. All 11 patients had arthalgia which was generally polyarticular, involving both small and large joints; four had arthalgia without frank arthritis, and six patients had acute, persistent, asymmetric, non-deforming, polyarthritis principally affecting the large joints, whereas one patient had acute nonspecific unilateral monoarthritis affecting the knee. Synovial fluid had rarely been available for examina- tion, and when available the findings were usually non-specific. Joint symptoms usually responded rapidly to treatment.
Liver
Hepatic abnormalities were seen in 50% (4/8) of the Swedish series: liver cirrhosis in one case, liver fibrosis in another, and persistently high hepatic transaminase levels in two. In the literature series, 67% (4/6) of the patients had hepatic abnormalities: one had cirrhosis, another had fibrosis, and another two patients had persistently high transaminase levels. Both cirrhotic patients were non-alcoholics, and patient 8, in whom hepatitis B and C markers were available, was negative for these markers. In both patients with liver fibrosis (6 and 9), liver fibrosis was diagnosed at autopsy. Acute abdominal pain was found in two patients (7 and 14) . Patient 7 had transient high transaminase levels suggestive of acute liver necrosis due to necrotizing vasculitis of hepatic vessels, and in patient 14 liver biopsy showed fatty changes. Patient 12, who had multiple hepatic artery aneurysms, died due to rupture of a branch of a hepatic artery aneurysm. Table 1 shows the clinical and histological findings of the liver involvement in both series.
Muscle
Symptomatic polymyalgia was present in 38% (3/8) of the Swedish series and 50% (3/6) of the literature series, in three cases reported to be severe. A muscle biopsy was performed in six patients, four with polymyalgia (patients 1, 6, 11 and 14) and two without myalgia (patients 4 and 9). Necrotizing vasculitis of small blood vessels was evident in all six cases in which biopsy was performed.
Gastrointestinal tract
Occult melaena was found in 50% (4/8) of the Swedish series (patients 2, 4, 6 and 8). In patient 4 it was due to haemorrhagic gastritis, and in patient 8 histological examination at autopsy showed the presence of focal mucosal necrosis in the stomach and small intestine, in part due to vasculitic changes. Fresh rectal bleeding (haematochezia), observed in patient 3 and interpreted as evidence of an acute attack of ulcerative colitis, responded to treatment with sulfasalazine (salazopyrine). Three years later the patient developed manifest vasculitic disease, and we consider his acute ulcerative colitis to have been a manifestation of his vasculitic syndrome. In the literature series, only patient 12 had occult melaena. This patient also had splenic infarctions due to focal necrotizing vasculitis of hepatic and splenic arteries with multiple aneurysms present in hepatic arteries as shown at autopsy. Haematochezia was observed in patient 10, in whom it was due to fulminant acute colitis, autopsy showing the presence of necrotizing vasculitis of medium-sized and smallsized colonic arteries. Ulcerations of the buccal mucosa were noted in three of the Swedish series and two of the literature series. In patient 11, biopsy showed the presence of post-vesicular ulceration with vasculitis of the small vessels with inflammatory infiltrates mostly of lymphocytes; and immunofluorescence study showed the presence of granular deposits of C3 in the walls of many small vessels.
Eye
Eye involvement was seen in four (50%) of the Swedish series, with episcleritis in patients 5 and 6, unilateral in patient 5. Patient 1 had acute bilateral non-specific anterior uveitis. Patient 7 had bilateral retinal haemorrhages and transient visual field defect. In the literature series, two (33%) of the patients had eye involvement (12 and 14) , one having bilateral non-specific anterior uveitis, and the other conjunctivitis. In two of the Swedish series, the eye lesions were noteworthy in that they were generally slow to respond to treatment of the underlying disease.
Nervous system
Peripheral nervous system involvement was present in 38% (3/8) of the Swedish series and 50% (3/6) of the literature series, sensory and/or motor mononeuritis being the predominant manifestation. Two patients had mononeuritis multiplex; in one of them necrotizing vasculitis of vasa nervosum had been found (patient 9). One patient had rapidly ascending mixed polyneuropathy, and another patient had polyradiculitis.
Heart
Heart involvement was seen in two of the Swedish series (patients 3 and 6) and one of the literature series (patient 12). Two were asymptomatic; patient 12 had small multiple myocardial infarcts with necrotizing vasculitis of coronary arteries and aneurysms of epicardial arteries seen at autopsy, and patient 6 also had necrotizing vasculitis of coronary arteries. Patient 3 has developed a severe dilated cardiomyopathy of unknown origin. Retrospectively, it is regarded as a feature of his vasculitic disease.
Miscellaneous
Necrotizing vasculitis was evident in the small-sized arteries of pancreas and adrenal glands of one of the Swedish series (patient 6), in whom histological evidence was also found of necrotizing vasculitis of the small branch of the temporal artery. Acute unilateral orchitis was found in patient 9, and histological examination at autopsy showed the presence of necrotizing vasculitis.
Biochemical findings
Of those for whom the pretreatment haemoglobin level was available, anaemia was found in 60% (3/5) of the Swedish series (median 8.9 g/dl, range 6.3-14.9 g/dl), but in none of the three patients in the literature series (median 12.4 g/dl, range 12.1-16.6 g/dl). The anaemia was generally normochromic and normocytic, and seems to have been chronic except in patient 7, in whom, anaemia was present two years before the onset of his microscopic polyangiititis, and was an idiopathic autoimmune haemolytic anaemia, with a positive Coomb's test and antibodies to IgG and to complement factor C3d; it improved with glucocorticoid therapy. Pretreatment WBCs were available for seven of the Swedish series and four of the literature series, leucocytosis being found in 85% (6/7) (median 12.3 x 1 0 9 , range 6.9-21.9 x 10 9 ) and 75% (3/4) (median 19.2 x 10 9 , range 7.7-25.0 x 10 9 ), respectively. It was predominantly neutrophilic in four patients (2, 8, 9 and 10) and predominantly eosinophilic only in patient 6. In the other four patients with leucocytosis (4, 5, 7 and 12), it was both neutrophilic and eosinophilic. Of those for whom pretreatment platelet counts were available, thrombocytosis was found in 60% (3/5) of the Swedish cases and 50% (2/4) of the literature cases. Pretreatment ESR was increased in 86% (6/7) of the Swedish patients (median 75 mm/h, range 10-112 mm/h), and in 80% (4/5) of the literature cases (median: 33 mm/h, range 10-95 mm/h). Of six Swedish patients and two patients of the literature series for whom pretreatment serum immunoglobulin levels were available, five had increased levels (usually of IgA and IgM). Pretreatment results of C1q binding assay of circulating immune complexes were available for two of the Swedish patients and three of the literature series, and were positive in three. Table 3 summarizes other laboratory findings in both series.
Treatment
The initial specific treatment given is shown in Table 4 . Eight patients received azathioprine and/or cyclophosphamide. Treatment with steroids (predni- RPGN, rapidly progressive glomerulonephritis; UP, ulcerative paniculitis; NV, necrotizing vasculitis; S, steroids; AZ, Azathioprine; CP, cyclophosphamide; HD, haemodialysis; RT, renal transplantation; PD, peritoneal dialysis; a,Pi = alpha 1-protease inhibitor (AAT); RF, renal failure; Ml, myocardial infarction; AIDS, acquired immunodeficiency syndrome; NS, not specified. * Patient had RPGN.
solone or other glucocorticoids) was used in 11 patients at some time during their treatment. Patient 3 was treated initially with azathioprine in addition to steroids, and due to inadequate response, azathioprine was replaced by cyclophosphamide and plasmapheresis was added. Recently, he received intravenous AAT (Prolastin). Patient 10 had fulminant haemorrhagic colitis, for which he received sulfasalazine (salazopyrine) in addition to steroids. Only patient 2 was untreated; she had relatively mild microscopic polyangiitis for which she did not need any specific treatment during 12 years of follow-up. Details of specific treatment were lacking (not specified) in two of the literature series (patients 9 and 13).
Maintenance haemodialysis was performed in three patients and peritoneal dialysis in one (patient 6). Another patient was treated with renal transplantation (patient 1).
Outcome
Of the series as a whole, 64% (9/14) died during the study period. Table 4 shows the outcome for all 14 patients. Most of the deaths were attributable to vasculitis, the major cause of death being renal insufficiency. Five patients (1, 6, 8, 9 and 10), died with end-stage renal failure which developed in 80% (4/5) of them (patients 6, 8, 9 and 10) 2, 1, 4, and 3 months, respectively, after the diagnosis of glomerulonephritis. One patient (patient 1), treated with haemodialysis for one year starting within 2 weeks of the development of severe renal failure, died two weeks after renal transplantation due to rejection. The severe renal failure of patient 5 was improved by immunosuppressive therapy. In this patient, pretreatment renal biopsy showed the presence of focal segmental necrotizing crescentic glomerulonephritis; two other biopsies, done after treatment with steroids and azathioprine and stabilization of the renal failure, showed the development of focal glomerular hyalinosclerosis and of membrano-proliferative glomerulonephritis, and immunofluorescence showed the presence of granular deposits of complement, IgA, IgG, and fibrin on the glomerular basement membrane. This patient later died of myocardial infarction. Patient 13 died from acquired immune deficiency syndrome (AIDS) due to frequent blood transfusions during haemodialysis; patient 7, who was severely handicapped by residual distal paralysis of the lower limbs due to motor mononeuritis multiplex, committed suicide.
Discussion
The relationship between AAT deficiency and systemic vasculitis can hardly be accidental. The overall annual incidence of systemic vasculitis (excluding giant cell arteritis) has recently been reported to be 3.9 per 100 000. 28 A paediatric population-based estimate of the annual incidence of HSP syndrome from Belfast, UK, was 13.5 per 100 000, 29 and the incidence has been estimated to be much lower in adults. The annual incidence of Wegener's granulomatosis is very low in developed countries, and has been estimated to be 0.4 per 100000 in Minnesota, USA, 30 where a large proportion of the population is of Scandinavian, particularly Swedish origin. Published estimates of the annual incidence of polyarteritis nodosa and microscopic polyangiitis in the general population in developed countries have ranged from 0.46 per 100 000 in England 31 to 0.9 per 100 000 in Minnesota, USA. 30 In the Swedish population, the frequency of AAT deficiency of the PiZZ phenotype is 1/1600 (0.06%), of the PiFZ phenotype 1/1400 (0.07%), and of the PiSZ phenotype 1/750 (0.13%). 32 ' 33 Thus the expected frequency of a chance combination of PiZ AAT deficiency and any variant of systemic vasculitis would seem to be very low unless relationship exists between these disorders. Furthermore, assuming the estimated annual incidence of microscopic polyangiitis in Sweden to be about 1 per 100000 and the total PiZZ population around 5000 individuals (or 9 000000/1666), if the conditions were not linked there would be five new such cases each century.
In the present study, with a much shorter time-frame, we identified five such patients at just three hospitals, with a total catchment area population of approximately 400 000. Systemic vasculitis is clearly overrepresented among individuals with severe AAT deficiency.
In an earlier report of 105 patients with PR3-ANCA-positive systemic vasculitis reported by us, 17 patients were found to be heterozygous (PiZ) and one homozygous (PiZZ) for AAT deficiency. 15 Follow-up evaluation of these patients showed PiZcarriers with PR3-ANCA-positive systemic vasculitis to have poorer prognosis than non-PiZ-carriers. 16 Findings in these studies and the present report, as well as studies by others, 14 ' 17 " 21 clearly suggest relationship to exist between these two diseases. Furthermore, the frequency of the PiZ allele was also significantly increased among patients with other forms of vasculitic diseases such as non-specific anterior uveitis, 34 ' 35 and fibrosing lung alveolitis; 36 at least two of the patients in this study had suffered from non-specific anterior uveitis (patients 1 and 12), and autopsy of patient 6 showed the presence of interstitial fibrosis and necrotizing vasculitis in both lungs. Finally, cutaneous vasculitic rashes of different types, particularly ulcerative panniculitis, acute ulcerative colitis and focal segmental necrotizing and crescentic glomerulonephritis (reported here as other manifestations of systemic vasculitis linked to severe AAT deficiency) have been observed by us and others as monosystemic disorders in at least 20 patients with AAT deficiency, the phenotypes represented being PiZZ, PiSZ, and PiMZ (Elzouki ef a/., unpublished data). Moreover, ulcerative panniculitis was present in two brothers both with the PiZZ phenotype, and skin biopsy in one of them showed the presence of vasculitis. 37 Although the basis of the relationship between severe AAT deficiency and vasculitis is unknown, in all likelihood it is similar to that of the relationship between PiZ heterozygosity and PR3-ANCA-positive vasculitis previously reported by us and others.
14 "
21
In our previous study we found vasculitis patients with moderate AAT deficiency to be characterized by a more widespread disease and worse prognosis, but found no differences in age at onset or relapse tendency. Accordingly, we concluded that, rather than being merely an aetiological risk factor, AAT deficiency may have an adverse accelerative effect on a vasculitic process once it starts, an interpretation consistent with the present findings. In the present study, patients with this peculiar syndrome of systemic vasculitis and severe AAT deficiency were characterized by manifest multiple organ involvement, and 89% (8/9) of those with severe renal involvement died-a rate far higher than those reported from most recent studies of rapidly progressive glomerulonephritis. In addition, the two patients with HSP syndrome presented in this study had an unusually severe course of renal involvement; in patient 8, rapidly progressive renal failure caused early death despite early immunosuppressive therapy; and in patient 13, the syndrome started in infancy as a typical HSP but progressed to a severe vasculitic rash involving diffuse areas all over his body and severe renal failure necessitating chronic dialysis (Sharp HL, personal communication). Although mortality in this cohort of patients was high, the 2-and 4-year survival rates were slightly better than those among heterozygotes in our previous study. 16 It is also noteworthy that all patients in the present study had skin involvement. In larger series of Wegener's granulomatosis 38 ' 39 and microscopic polyangiitis, 40 the figures are usually 25-45% and 60%, respectively. In addition, another important feature of systemic vasculitis linked with severe AAT deficiency was the association with panlobular emphysema, even in non-smokers, and with liver parenchymal diseases; these related conditions were the first to be published as being linked with AAT deficiency. 32 '
41
AAT is the major physiological inhibitor of HLE and PR3. HLE and PR3 are neutral serine proteinases (SERPs) synthesized by the precursors of granulocytic cells i.e. monocytes-macrophages and neutrophils, and are present with myeloperoxidase in their primary azurophilic granules. These enzymes are partially released extracellularly in response to cellular activation by phagocytosis of circulating immune complexes. 42^4 By inhibiting leucocyte SERPs, AAT may regulate in vivo the inflammatory response that is the result of the four basic types of the immune reactions; each of these reactions may be involved in the pathogenesis of systemic necrotizing vasculitides; 45 and AAT deficiency may thus enhance this response, resulting in hypersensitivity and disease. AAT may protect the endothelium against leucocyte SERPs 46 and vascular and perivascular elastin against HLE or PR3. In rats, elastase can experimentally induce vascular aneurysms, and increased elastase activity may be involved in the spontaneous rupture of internal elastic lamina. 47 ' 48 Of special interest is the case of aneurysm of medium-sized abdominal vessels (patient 12), where the rupture of a hepatic artery aneurysm was the cause of death. The frequency of abdominal vessel aneurysms has been reported to be 47% among patients with polyarteritis nodosa and 17% among patients with Wegener's granulomatosis. 49 Several studies have shown elastase activity to be increased in aneurysmal tissue. 50 ' 51 A significant alteration of the balance between AAT and elastase at the tissue level has been found in patients with abdominal aortic aneurysms. 52 Moreover, recent findings suggest the AAT concentration to be lower in patients with multiple aneurysms and ruptured aneurysms than in patients with occlusive aortic disease. 53 Cases have been recently reported of abdominal vessel aneurysms and either heterozygous 54 or homozygous 55 AAT deficiency. A possible relationship between heterozygous AAT deficiency and abdominal aortic aneurysm has also been reported, 56 although other studies failed to show the existence of any such relationship, at least in homozygous AAT deficiency. 54 ' 57 Furthermore, the cause of death in 91 adults with PiZZ AAT deficiency was reported to have been due to subarachnoidal bleeding in two patients, and to other intracerebral cerebral vascular lesions in another two patients. 58 However, we found no significant relationship between severe AAT deficiency and intracranial aneurysms. 59 Another feature of particular interest in this study is the cases of acute ulcerative colitis (patients 3 and 10). Recent findings have suggested a relationship between the anatomy of the marginal artery and the proximal extent of ulcerative colitis. 60 The authors of that study concluded that characteristics of the mucosal microvasculature in the territory of the inferior mesenteric artery, possibly embryological in origin, predispose to ulcerative colitis. A case reported by Mitchell and coworkers 55 not only included a ruptured mesenteric artery aneurysm but multiple small aneurysms of the middle colic artery as well. In the Swedish national registry for severe AAT deficiency, started in 1991 and comprising approximately 500 cases, we located ten patients with ulcerative colitis, i.e. 1/50, or 20-fold more than the expected prevalence in Sweden of 50-100/10 5 (Elzouki et al., unpublished data).
Although neither the Swedish series nor the literature series yielded any information about the frequency and pattern of relapse of systemic vasculitis in cases of severe AAT deficiency, they did provide information about the frequency of organ involvement, various clinical and laboratory manifestations, and outcome. A part from universal cutaneous involvement, severity of renal disease, high risk of dissemination of the vasculitic process, and fatal outcome, patients in the two present series did not appear to differ from others with systemic vasculitis and non-PiZ carriers reported previously. 15 ' 16 To sum up, patients with systemic necrotizing vasculitis and severe AAT deficiency are characterized by manifest multiple organ involvement and fatal outcome. We believe the combination of systemic vasculitis and AAT deficiency to be easily missed by physicians, who should check for the presence of the PiZ allele for AAT deficiency in patients with systemic vasculitis, especially when the course is progressive and when emphysema or chronic liver disease is present. The seriousness of the condition and the probable pathogenic involvement of AAT deficiency in the pathogenesis of systemic vasculitis suggests a multicentre control trial to study the efficiency of AAT replacement therapy.
